PortfoliosLab logoPortfoliosLab logo
JD vs. CME
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

JD vs. CME - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in JD.com, Inc. (JD) and CME Group Inc. (CME). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, JD achieves a 10.42% return, which is significantly higher than CME's -7.62% return. Over the past 10 years, JD has underperformed CME with an annualized return of 4.77%, while CME has yielded a comparatively higher 13.48% annualized return.


JD

1D
3.31%
1M
10.99%
6M
9.66%
YTD
10.42%
1Y
-6.57%
3Y*
-3.26%
5Y*
-14.24%
10Y*
4.77%
ALL TIME*
3.97%

CME

1D
0.02%
1M
-0.52%
6M
-9.74%
YTD
-7.62%
1Y
-7.30%
3Y*
13.77%
5Y*
7.36%
10Y*
13.48%
ALL TIME*
19.41%
*Multi-year figures are annualized to reflect compound growth (CAGR)

JD vs. CME - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
JD
JD.com, Inc.
10.42%-14.78%23.45%-47.76%-17.87%-20.28%149.50%68.32%-49.47%62.81%
CME
CME Group Inc.
-7.62%19.83%15.41%31.32%-22.89%29.47%-6.34%9.67%32.15%32.35%

Correlation

The correlation between JD and CME is 0.00, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.00

Correlation (3Y)
Calculated over the trailing 3-year period

-0.01

Correlation (5Y)
Calculated over the trailing 5-year period

0.06

Correlation (10Y)
Calculated over the trailing 10-year period

0.08

Correlation (All Time)
Calculated using the full available price history since May 22, 2014

0.10

The correlation between JD and CME shifts across timeframes, from -0.01 (3 years) to 0.10 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

JD:

$42.96B

CME:

$88.82B

EPS

JD:

CN¥9.41

CME:

$11.74

PE Ratio

JD:

22.02

CME:

20.87

PEG Ratio

JD:

1.08

CME:

1.82

PS Ratio

JD:

0.23

CME:

13.10

PB Ratio

JD:

1.38

CME:

3.34

Total Revenue (TTM)

JD:

CN¥1.32T

CME:

$6.76B

Gross Profit (TTM)

JD:

CN¥126.44B

CME:

$5.84B

EBITDA (TTM)

JD:

CN¥27.03B

CME:

$5.69B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

JD vs. CME — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

JD
JD Risk / Return Rank: 3535
Overall Rank
JD Sharpe Ratio Rank: 3636
Sharpe Ratio Rank
JD Sortino Ratio Rank: 3232
Sortino Ratio Rank
JD Omega Ratio Rank: 3232
Omega Ratio Rank
JD Calmar Ratio Rank: 3838
Calmar Ratio Rank
JD Martin Ratio Rank: 3838
Martin Ratio Rank

CME
CME Risk / Return Rank: 3131
Overall Rank
CME Sharpe Ratio Rank: 3131
Sharpe Ratio Rank
CME Sortino Ratio Rank: 2727
Sortino Ratio Rank
CME Omega Ratio Rank: 2727
Omega Ratio Rank
CME Calmar Ratio Rank: 3737
Calmar Ratio Rank
CME Martin Ratio Rank: 3131
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

JD vs. CME - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for JD.com, Inc. (JD) and CME Group Inc. (CME). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


JDCMEDifference
Sharpe ratioReturn per unit of total volatility

+0.12

Sortino ratioReturn per unit of downside risk

+0.21

Omega ratioGain probability vs. loss probability

0.99

0.96

+0.03

Calmar ratioReturn relative to maximum drawdown

-0.22

-0.24

+0.01

Martin ratioReturn relative to average drawdown

-0.40

-0.73

+0.32

JD vs. CME - Sharpe Ratio Comparison

The current JD Sharpe Ratio is -0.21, which is higher than the CME Sharpe Ratio of -0.32. The chart below compares the historical Sharpe Ratios of JD and CME, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

JD vs. CME - Drawdown Comparison

The maximum JD drawdown since its inception was -79.12%, roughly equal to the maximum CME drawdown of -77.50%. Use the drawdown chart below to compare losses from any high point for JD and CME.


Loading charts...

Drawdown Indicators


JDCMEDifference

Max Drawdown

Largest peak-to-trough decline

-79.12%

-77.50%

-1.62%

Max Drawdown (1Y)

Largest decline over 1 year

-29.78%

-31.09%

+1.31%

Max Drawdown (3Y)

Largest decline over 3 years

-48.10%

-31.09%

-17.01%

Max Drawdown (5Y)

Largest decline over 5 years

-75.63%

-31.74%

-43.89%

Max Drawdown (10Y)

Largest decline over 10 years

-79.12%

-37.36%

-41.76%

Current Drawdown

Current decline from peak

-67.32%

-22.73%

-44.59%

Average Drawdown

Average peak-to-trough decline

-37.88%

-20.70%

-17.18%

Ulcer Index

Depth and duration of drawdowns from previous peaks

16.44%

10.08%

+6.36%

Volatility

JD vs. CME - Volatility Comparison

JD.com, Inc. (JD) and CME Group Inc. (CME) have volatilities of 8.96% and 9.30%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


JDCMEDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.96%

9.30%

-0.34%

Volatility (6M)

Calculated over the trailing 6-month period

23.34%

18.97%

+4.37%

Volatility (1Y)

Calculated over the trailing 1-year period

32.04%

22.66%

+9.38%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

53.68%

20.49%

+33.19%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

47.73%

24.06%

+23.67%

Dividends

JD vs. CME - Dividend Comparison

JD's dividend yield for the trailing twelve months is around 3.27%, less than CME's 4.59% yield.


PositionTTM20252024202320222021202020192018201720162015
CME
CME Group Inc.
4.59%1.83%4.48%4.58%5.05%3.00%3.24%2.74%2.42%4.20%4.90%5.41%
JD
JD.com, Inc.
3.27%3.48%2.19%2.15%2.24%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

JD vs. CME - Financials Comparison

This section allows you to compare key financial metrics between JD.com, Inc. and CME Group Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00100.00B200.00B300.00B400.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
313.78B
1.88B
(JD) Total Revenue
(CME) Total Revenue
Please note, different currencies. JD values in CNY, CME values in USD

JD vs. CME - Profitability Comparison

The chart below illustrates the profitability comparison between JD.com, Inc. and CME Group Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
16.7%
88.1%
Portfolio components
JD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, JD.com, Inc. reported a gross profit of 52.43B and revenue of 313.78B. Therefore, the gross margin over that period was 16.7%.

CME - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, CME Group Inc. reported a gross profit of 1.66B and revenue of 1.88B. Therefore, the gross margin over that period was 88.1%.

JD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, JD.com, Inc. reported an operating income of 3.78B and revenue of 313.78B, resulting in an operating margin of 1.2%.

CME - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, CME Group Inc. reported an operating income of 1.31B and revenue of 1.88B, resulting in an operating margin of 69.7%.

JD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, JD.com, Inc. reported a net income of 5.07B and revenue of 313.78B, resulting in a net margin of 1.6%.

CME - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, CME Group Inc. reported a net income of 1.15B and revenue of 1.88B, resulting in a net margin of 61.4%.


Frequently Asked Questions


JD and CME have a correlation of 0.00, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CME has higher volatility (9.30%) compared to JD (8.96%). In terms of maximum drawdown, JD dropped -79.12% vs CME's -77.50%.

JD currently has the higher Sharpe Ratio (-0.21 vs -0.32), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for JD and CME

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer